First generic versions of Singulair receive FDA approval for treatment of asthma, allergies
22:06 EDT 5 Aug 2012 | The Medical News
The U.S. Food and Drug Administration today approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies.
Original Article: First generic versions of Singulair receive FDA approval for treatment of asthma, allergies
More From BioPortfolio on "First generic versions of Singulair receive FDA approval for treatment of asthma, allergies"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
